HETEROCYCLIC COMPOUNDS AS HIV PROTEASE INHIBITORS

The present invention is directed to compounds of Formula I pharmaceutical compositions comprising the same, and their use in the inhibition of HIV protease, the inhibition of HIV replication, the prophylaxis of infection by HIV, the treatment of infection by HIV, and the prophylaxis, treatment, and...

Full description

Saved in:
Bibliographic Details
Main Authors YING, Shihong, WILLIAMS, Peter, D, MCKITTRICK, Brian, MCCAULEY, John, A, VACCARO, Henry, CHAN, Tin-Yau, CALDWELL, John, P, KHAN, Tanweer, NOLT, M. Brad, KIM, Jae-Hun, KIM, Hyunjin, HONG, Liwu, CAPLEN, Mary Ann, WANG, Hongwu, SMITH, Elizabeth
Format Patent
LanguageEnglish
French
German
Published 19.08.2020
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:The present invention is directed to compounds of Formula I pharmaceutical compositions comprising the same, and their use in the inhibition of HIV protease, the inhibition of HIV replication, the prophylaxis of infection by HIV, the treatment of infection by HIV, and the prophylaxis, treatment, and delay in the onset or progression of AIDS.
Bibliography:Application Number: EP20170883610